Bahar ME, Kim HJ, Kim DR. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. Sig Transduct Target Ther. 2023;8:1–38.

Article  Google Scholar 

Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5:8.

Article  PubMed  PubMed Central  Google Scholar 

Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, et al. A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers. 2019;11:1618.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee S, Rauch J, Kolch W. Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci. 2020;21:1102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiology and Molecular Biology Reviews : MMBR. 2011;75:50.

Breast cancer [Internet]. [cited 2025 Feb 3]. Available from: https://www.who.int/news-room/fact-sheets/detail/breast-cancer

Kubatka P, Koklesova L, Mazurakova A, Brockmueller A, Büsselberg D, Kello M, et al. Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling. Cancer Metastasis Rev. 2023;43:87.

Article  PubMed  PubMed Central  Google Scholar 

Wang P, Laster K, Jia X, Dong Z, Liu K. Targeting CRAF kinase in anti-cancer therapy: progress and opportunities. Mol Cancer. 2023;22:208.

Article  PubMed  PubMed Central  Google Scholar 

Samec M, Liskova A, Koklesova L, Samuel SM, Zhai K, Buhrmann C, et al. Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. EPMA J. 2020;11:377–98.

Article  PubMed  PubMed Central  Google Scholar 

Tian H, Ma D, Tan X, Yan W, Wu X, He C, et al. Platinum and taxane based adjuvant and neoadjuvant chemotherapy in early triple-negative breast cancer: a narrative review. Front Pharmacol. 2021;12: 770663.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sazonova EV, Kopeina GS, Imyanitov EN, Zhivotovsky B. Platinum drugs and taxanes: can we overcome resistance? Cell Death Discovery. 2021;7:155.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nath SD, Shoily SS, Fatema K, Khan A, Mostafa MG, Sajib AA. Pan-cancer chemoresistance-associated genes, affected pathways and potential therapeutic targets. Human Gene. 2023;35: 201151.

Article  CAS  Google Scholar 

Eralp Y, Derin D, Ozluk Y, Yavuz E, Guney N, Saip P, et al. MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer. Ann Oncol. 2008;19:669–74.

Article  CAS  PubMed  Google Scholar 

Talib WH, Alsayed AR, Barakat M, Abu-Taha MI, Mahmod AI. Targeting drug chemo-resistance in cancer using natural products. Biomedicines. 2021;9:1353.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu J, Mu Q, Fung M, Xu X, Zhu L, Ho RJ. Challenges and opportunities in metastatic breast cancer treatments: nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response. Pharmacol Ther. 2022;236: 108108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi Z-D, Pang K, Wu Z-X, Dong Y, Hao L, Qin J-X, et al. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies. Sig Transduct Target Ther. 2023;8:1–21.

Article  CAS  Google Scholar 

Gui T, Sun Y, Shimokado A, Muragaki Y. The roles of mitogen-activated protein kinase pathways in TGF-β-induced epithelial-mesenchymal transition. J Signal Transduction. 2012;2012: 289243.

Article  Google Scholar 

Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Science signaling. 2014;7:re8.

Xu M, Wang S, Wang Y, Wu H, Frank JA, Zhang Z, et al. Role of p38γ MAPK in regulation of EMT and cancer stem cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018;1864:3605–17.

Sippel RS, Chen H. Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation. Surgery. 2002;132:1035–9.

Article  PubMed  Google Scholar 

Liskova A, Samec M, Koklesova L, Brockmueller A, Zhai K, Abdellatif B, et al. Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles. EPMA J. 2021;1–22.

Park MY, Kim Y, Ha SE, Kim HH, Bhosale PB, Abusaliya A, et al. Function and application of flavonoids in the breast cancer. Int J Mol Sci. 2022;23:7732.>

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mir SA, Dar A, Hamid L, Nisar N, Malik JA, Ali T, et al. Flavonoids as promising molecules in the cancer therapy: an insight. Current Research in Pharmacology and Drug Discovery. 2024;6: 100167.

Article  PubMed  Google Scholar 

Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci. 2016;5: e47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Safe S, Jayaraman A, Chapkin RS, Howard M, Mohankumar K, Shrestha R. Flavonoids: structure–function and mechanisms of action and opportunities for drug development. Toxicological Research. 2021;37:147.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hasnat H, Shompa SA, Islam MdM, Alam S, Richi FT, Emon NU, et al. Flavonoids: a treasure house of prospective pharmacological potentials. Heliyon. 2024;10:e27533.

Mazurakova A, Koklesova L, Vybohova D, Samec M, Kudela E, Biringer K, et al. Therapy-resistant breast cancer in focus: clinically relevant mitigation by flavonoids targeting cancer stem cells. Front Pharmacol. 2023;14:1160068.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mansuri ML, Parihar P, Solanki I, Parihar MS. Flavonoids in modulation of cell survival signalling pathways. Genes Nutr. 2014;9:400.

Article  PubMed  PubMed Central  Google Scholar 

Shi A, Liu L, Li S, Qi B. Natural products targeting the MAPK-signaling pathway in cancer: overview. J Cancer Res Clin Oncol. 2024;150:6.

Article  PubMed  PubMed Central  Google Scholar 

Leary M, Heerboth S, Lapinska K, Sarkar S. Sensitization of drug resistant cancer cells: a matter of combination therapy. Cancers. 2018;10:483.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev. 1999;79:143–80.

Article  CAS  PubMed  Google Scholar 

Guo Y-J, Pan W-W, Liu S-B, Shen Z-F, Xu Y, Hu L-L. ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19:1997–2007.

PubMed  PubMed Central  Google Scholar 

Burotto M, Chiou VL, Lee J-M, Kohn EC. The MAPK pathway across different malignancies: a new perspective. Cancer. 2014;120:3446–56.

Article  CAS  PubMed  Google Scholar 

Maik-Rachline G, Hacohen-Lev-Ran A, Seger R. Nuclear ERK: mechanism of translocation, substrates, and role in cancer. Int J Mol Sci. 2019;20:1194.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhat GR, Sethi I, Sadida HQ, Rah B, Mir R, Algehainy N, et al. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance. Cancer Metastasis Rev. 2024;43:197–228.

Article  PubMed  PubMed Central  Google Scholar 

Breast Cancer Facts and Statistics 2024 [Internet]. [cited 2024 Nov 28]. Available from: https://www.breastcancer.org/facts-statistics

Whyte J, Bergin O, Bianchi A, McNally S, Martin F. Key